Choose your country to see the products for your location

Highlighted

View all

Updates to our DMD Portfolio

We are pleased to share an important update to our Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) portfolio. Improved versions of our MLPA assays for DMD copy number analysis are now available, offering enhanced performance and quality control. Read more.

New Product: NXtec D028 Carrier Panel 1

We are proud to introduce NXtec D028 Carrier Panel 1 - a high-throughput assay detecting CNVs and selected SNVs for carrier status analysis. Read more.

NXtec D007 Acute Lymphoblastic Leukemia as a Valuable Tool in pALL Testing

D007 Acute Lymphoblastic Leukemia was recognized as a valuable tool for enhanced molecular testing of pediatric acute lympoblastic leukemia (pALL) in a recent research article. Read more.

Latest News

  • Mar 22, 2026

    Our Products are IVDR-Certified!

    We have successfully obtained our certification under the new In Vitro Diagnostic Regulation (IVDR; 2017/746)! The first batch of flagship products are already available on the market under the new IVDR, well in advance of the transition period deadline. Read more.

  • Mar 20, 2026

    Wanted: DNA Samples

    MRC Holland is looking for DNA samples for the development and quality control of our many products.

  • Mar 03, 2026

    Updates to our DMD Portfolio

    We are pleased to share an important update to our Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) portfolio. Improved versions of our MLPA assays for DMD copy number analysis are now available, offering enhanced performance and quality control. Read more.

Come and Meet Us

Stay in Touch

Join our mailing list to receive the latest information about our products, technologies and website.

This site uses cookies to help improve your online experience. Learn more
No, thank you accept

Sign in

Don't have an account? Create one

Forgot password?

Select Your Country

Choose your country to see the products for your location